From: Physical comorbidities in men with mood and anxiety disorders: a population-based study
 |  | Mood disorders | Anxiety disorders | |||||
---|---|---|---|---|---|---|---|---|
Model | Odds ratio | 95% CI | Pvalue | Odds ratio | 95% CI | Pvalue | ||
Musculoskeletal disease | I | 1.43 | (0.93 to 2.21) | 0.104 | 1.39 | (0.72 to 2.71) | 0.328 | |
II | 1.47 | (0.94 to 2.31) | 0.092 | 1.70 | (0.85 to 3.43) | 0.135 | ||
Thyroid disorders | I | 1.64 | (0.52 to 5.12) | 0.396 | 5.29 | (1.63 to 7.14) | 0.005 | |
II | 1.81 | (0.56 to 5.83) | 0.321 | 5.54 | (1.64 to 18.64) | 0.006 | ||
Metabolic risk factors | I | 1.30 | (0.85 to 1.99) | 0.234 | 1.92 | (0.96 to 3.83) | 0.066 | |
IIa | 1.29 | (0.83 to 2.00) | 0.265 | 2.20 | (1.07 to 4.53) | 0.032 | ||
GORD | I | 2.41 | (1.48 to 3.00) | <0.001 | 3.84 | (2.01 to 7.33) | <0.001 | |
II | 2.67 | (1.60 to 4.47) | <0.001 | 4.25 | (2.18 to 8.26) | <0.001 | ||
Gastrointestinal disorders | I | 1.47 | (0.93 to 2.30) | 0.096 | 2.22 | (1.20 to 4.10) | 0.011 | |
II | 1.46 | (0.91 to 2.34) | 0.112 | 2.40 | (1.28 to 4.50) | 0.006 | ||
Recurrent headaches | I | 2.46 | (1.29 to 4.69) | 0.007 | 0.63 | (0.15 to 2.69) | 0.537 | |
II | 2.53 | (1.30 to 4.96) | 0.007 | 0.67 | (0.16 to 2.89) | 0.592 | ||
Syncope and seizures | I | 2.01 | (1.31 to 3.09) | 0.002 | 1.46 | (0.75 to 2.85) | 0.263 | |
II | 2.01 | (1.28 to 3.16) | 0.002 | 1.55 | (0.78 to 3.07) | 0.207 | ||
Cardiovascular disease | I | 1.27 | (0.82 to 1.93) | 0.292 | 1.93 | (0.60 to 2.13) | 0.708 | |
II | 1.28 | (0.82 to 2.01) | 0.276 | 1.15 | (0.59 to 2.25) | 0.678 | ||
Pulmonary disease | All | I | - | - | - | 0.95 | (0.48 to 1.86) | 0.874 |
II | - | - | - | 1.02 | (0.51 to 2.03) | 0.956 | ||
<60 years old | I | 0.90 | (0.52 to 1.58) | 0.725 | - | - | - | |
II | 1.01 | (0.57 to 1.79) | 0.971 | - | - | - | ||
≥60 years old | I | 2.75 | (1.45 to 5.21) | 0.002 | - | - | - | |
II | 2.65 | (1.34 to 5.21) | 0.005 | - | - | - | ||
Liver disorders | I | 2.64 | (1.40 to 4.98) | 0.003 | 0.97 | (0.29 to 3.24) | 0.964 | |
II | 3.03 | (1.57 to 5.83) | 0.001 | 1.03 | (0.30 to 3.46) | 0.967 | ||
Cancer | I | 0.95 | (0.56 to 1.61) | 0.839 | 1.03 | (0.47 to 2.29) | 0.933 | |
II | 0.90 | (0.52 to 1.56) | 0.706 | 1.03 | (0.46 to 2.32) | 0.938 | ||
Psoriasis | I | 1.63 | (0.75 to 3.55) | 0.219 | 2.44 | (0.91 to 6.57) | 0.076 | |
II | 1.41 | (0.51 to 2.91) | 0.648 | 2.77 | (1.00 to 7.67) | 0.049 | ||
High medical burden | I | 1.80 | (1.16 to 2.77) | 0.008 | 2.82 | (1.43 to 5.53) | 0.003 | |
IIa | 1.86 | (1.19 to 2.91) | 0.007 | 3.23 | (1.61 to6.47) | 0.001 |